Evidence map›Paper›PMID 39212966›Full record

ArticleGenome biology and evolution2024

Sequence, Structure, and Functional Space of Drosophila De Novo Proteins.

Lasse Middendorf, Bharat Ravi Iyengar, Lars A Eicholt

Abstract read
In one paragraph

Article in Genome biology and evolution, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Sketching microprotein portraits.Protein science : a publication of the Protein Society · 2026
    Review
  4. Article
  5. Article
  6. Impact of GC content on de novo gene birth.Nature communications · 2026
    Article
  7. Review
  8. Review
  9. TheBioinformatics advances · 2025
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lasse MiddendorfInstitute for Evolution and Biodiversity, University of Muenster, Huefferstrasse 1, 48149 Muenster, Germany.ORCID 0009-0008-0709-4990
Bharat Ravi IyengarInstitute for Evolution and Biodiversity, University of Muenster, Huefferstrasse 1, 48149 Muenster, Germany.ORCID 0000-0002-8983-4153
Lars A EicholtInstitute for Evolution and Biodiversity, University of Muenster, Huefferstrasse 1, 48149 Muenster, Germany.ORCID 0000-0002-3985-3698

Funding

Deutsche Forschungsgemeinschaft INST 211/667-1
6 · The paper itself

Abstract

During de novo emergence, new protein coding genes emerge from previously nongenic sequences. The de novo proteins they encode are dissimilar in composition and predicted biochemical properties to conserved proteins. However, functional de novo proteins indeed exist. Both identification of functional de novo proteins and their structural characterization are experimentally laborious. To identify functional and structured de novo proteins in silico, we applied recently developed machine learning based tools and found that most de novo proteins are indeed different from conserved proteins both in their structure and sequence. However, some de novo proteins are predicted to adopt known protein folds, participate in cellular reactions, and to form biomolecular condensates. Apart from broadening our understanding of de novo protein evolution, our study also provides a large set of testable hypotheses for focused experimental studies on structure and function of de novo proteins in Drosophila.

Indexed as

Drosophila ProteinsAnimalsBiomolecular CondensatesDrosophilaDrosophila melanogasterEvolution, MolecularMachine LearningProtein FoldingDrosophila Proteinsde novo proteinsprotein functionprotein structuresequence spacestructural comparisonstructure predictions

Identifiers

PMID39212966
PMCPMC11363682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.